Identification of druggable oncogenic gene fusions and a novel mechanism of drug resistance in lung cancer

被引:0
|
作者
Nakaoku, Takashi [1 ]
Kohno, Takashi [1 ,2 ]
机构
[1] Natl Canc Ctr Res, Div Genome Biol, Tokyo, Japan
[2] Natl Canc Ctr, EPOC, Div Translat Genom, Tokyo, Japan
来源
CANCER SCIENCE | 2018年 / 109卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
YIA-7
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
  • [41] Identification of Novel Oncogenic Mutations in Thyroid Cancer
    Pitt, Susan C.
    Hernandez, Roland A.
    Nehs, Matthew A.
    Gawande, Atul A.
    Moore, Francis D., Jr.
    Ruan, Daniel T.
    Cho, Nancy L.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (06) : 1036 - 1043
  • [42] Mechanism of drug resistance in non-small-cell lung cancer
    Nature Clinical Practice Oncology, 2005, 2 (4): : 177 - 177
  • [43] Identification of Mechanisms of Drug Resistance in RET-Rearranged Lung Cancer
    Nakaoku, T.
    Kohno, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2276 - S2276
  • [44] Identification of mechanisms of drug resistance in RET-rearranged lung cancer
    Nakaoku, Takashi
    Kohno, Takashi
    CANCER SCIENCE, 2018, 109 : 740 - 740
  • [45] A novel fusion gene responsible for colon cancer drug resistance
    Xie, Jingwu
    Gu, Dongsheng
    Song, Ruolan
    CANCER RESEARCH, 2018, 78 (13)
  • [46] Drug resistance in lung cancer
    Shanker, Manish
    Willcutts, David
    Roth, Jack A.
    Ramesh, Rajagopal
    LUNG CANCER-TARGETS AND THERAPY, 2010, 1 : 23 - 36
  • [47] Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
    Scott A. Tomlins
    Bharathi Laxman
    Saravana M. Dhanasekaran
    Beth E. Helgeson
    Xuhong Cao
    David S. Morris
    Anjana Menon
    Xiaojun Jing
    Qi Cao
    Bo Han
    Jindan Yu
    Lei Wang
    James E. Montie
    Mark A. Rubin
    Kenneth J. Pienta
    Diane Roulston
    Rajal B. Shah
    Sooryanarayana Varambally
    Rohit Mehra
    Arul M. Chinnaiyan
    Nature, 2007, 448 : 595 - 599
  • [48] Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
    Tomlins, Scott A.
    Laxman, Bharathi
    Dhanasekaran, Saravana M.
    Helgeson, Beth E.
    Cao, Xuhong
    Morris, David S.
    Menon, Anjana
    Jing, Xiaojun
    Cao, Qi
    Han, Bo
    Yu, Jindan
    Wang, Lei
    Montie, James E.
    Rubin, Mark A.
    Pienta, Kenneth J.
    Roulston, Diane
    Shah, Rajal B.
    Varambally, Sooryanarayana
    Mehra, Rohit
    Chinnaiyan, Arul M.
    NATURE, 2007, 448 (7153) : 595 - U9
  • [49] THE MECHANISM BY WHICH HFE GENE VARIANTS CONFER DRUG RESISTANCE IN CANCER
    Lee, Sang Y.
    Slagle-Webb, Becky
    Farace, Elana
    Sheehan, Jonas
    Connor, James R.
    NEURO-ONCOLOGY, 2009, 11 (05) : 573 - 573
  • [50] Gene fusions in non-small-cell lung cancer
    Yang, Lu-Lu
    Wu, Yi-Long
    LUNG CANCER MANAGEMENT, 2012, 1 (04) : 283 - 292